Peer Review History
| Original SubmissionJanuary 10, 2025 |
|---|
|
PONE-D-25-01163 Association between serum zinc and serum neurofilament light chains: A population-based analysis PLOS ONE Dear Dr. Liu, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jun 16 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Huzaifa Umar Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1.Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Thank you for uploading your study's underlying data set. Unfortunately, the repository you have noted in your Data Availability statement does not qualify as an acceptable data repository according to PLOS's standards. At this time, please upload the minimal data set necessary to replicate your study's findings to a stable, public repository (such as figshare or Dryad) and provide us with the relevant URLs, DOIs, or accession numbers that may be used to access these data. For a list of recommended repositories and additional information on PLOS standards for data deposition, please see https://journals.plos.org/plosone/s/recommended-repositories . [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: 1.technical and grammar are needed to be checked. 2. Percent of male and female was not presented in the study. 3. plagiarism report need to be submitted 4. two studies need to be acknowledged in this study; a- https://www.frontiersin.org/journals/aging-neuroscience/articles/10.3389/fnagi.2025.1517663/full b-https://pubmed.ncbi.nlm.nih.gov/32258830/ 5. Graphs or tables need to be added Reviewer #2: In this intriguing article, the authors investigated the association between serum zinc levels and serum neurofilament light chain (sNfL) levels in the general population, utilizing data from the National Health and Nutrition Examination Survey (NHANES) conducted in 2013-2014. Their analysis included a total population of 585 adults and revealed a significant negative association between serum zinc levels and sNfL, with a p-value at the margins of significance (0.0321). Stratified analyses indicated that this negative association was significant only among divorced, widowed, or separated individuals. Given these results, I believe the abstract's conclusion is somewhat overstated in asserting that serum zinc could serve as a novel predictor for the onset and progression of neurological disorders. Zinc is an essential micronutrient that plays various roles in the nervous system, and both its deficiency and excess can lead to several issues. In my opinion, the introduction is overly generic and should delve deeper into the essential activities in which zinc is involved within the nervous system. I would eliminate the sections pertaining to wound healing, tissue reconstruction, growth, and immune system function, as they are not directly relevant and rather superficial. Furthermore, the interaction between zinc intake and other micronutrients (such as copper) is not addressed. The potential association of copper deficiency myelopathy, which may arise as a complication of excessive zinc supplementation, should be cited (see DOI: 10.1001/archneur.61.5.762 and DOI: 10.1179/2045772314Y.0000000268). Other suggestions follow: - Smooth curve-fitting models revealed an L-shaped association between serum zinc levels and sNfL, as depicted in Figure 2. Threshold effect analyses (Table 3) indicated that the lowest threshold for a protective effect was 10.21 nmol/L (log-likelihood ratio < 0.001). However, even if not statistically significant, a careful observation of Figure 2 reveals an increase on the right side of the curve, with higher serum concentrations of zinc associating with increased levels of serum NfL. I believe this is important since excessive zinc intake has been associated with decreased concentrations of copper. - In the limitations section, it should be noted that for the size of the population, a significance level of p = 0.0321 is relatively low. - The explanation of the subgroup analyses, which revealed that the relationship between serum zinc and sNfL was particularly pronounced among divorced, widowed, or separated individuals, appears insufficiently incisive. It is appropriate to highlight that changes in marital status can influence the onset and progression of neurodegenerative diseases, but the possible mechanisms should be better specified. Are there data on the diet and potential micronutrient deficiencies in this population of individuals? - When discussing micronutrient and vitamin deficiencies and the incidence of disease, it should be acknowledged that low nutrient levels may reflect poor dietary habits, low levels of physical exercise, and can be influenced by many health factors, including body mass index. Therefore, micronutrient levels should not be considered solely as an indicator of nutritional status but also as a marker of overall health (e.g., for vitamin D, see DOI: 10.3390/nu7075111). ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy . Reviewer #1: Yes: Umar Muhammad Ghali Reviewer #2: Yes: Domenico Plantone ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
<p>Association between serum zinc and serum neurofilament light chains: A population-based analysis PONE-D-25-01163R1 Dear Dr. Yang Liu, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Huzaifa Umar Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-25-01163R1 PLOS ONE Dear Dr. Liu, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Huzaifa Umar Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .